Supplementation was well-tolerated with no related adverse events, no episodes of hypercalcemia, and high reported compliance.
Frontiers in Nutrition · 10 authors, 4 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
Supplementation was well-tolerated with no related adverse events, no episodes of hypercalcemia, and high reported compliance.
Supplementation was well-tolerated with no related adverse events, no episodes of hypercalcemia, and high reported compliance. Supplemented patients had markedly higher 25OHD on the day of surgery (103.9 vs. 42.5 nmol/l, P = 8.2E-12) and at all post-operative timepoints, with multivariate modeling showing an estimated 59.4 nmol/l higher 25OHD (P = 3.7E-21). The post-operative drop in 25OHD was attenuated (24% vs. 129 mg/l at days 3-5, P = 0.04).